Azenta, Inc. (AZTA) vs Trevi Therapeutics, Inc. (TRVI)
A side-by-side comparison of Azenta, Inc. and Trevi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AZTA
Azenta, Inc.
$39.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TRVI
Trevi Therapeutics, Inc.
$13.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AZTA vs TRVI
growth of $100 · dividends reinvested · last 7yAZTA +11.6% (+1.6%/yr)TRVI +73.9% (+8.2%/yr)TRVI compounded faster over this window
AZTA TRVI
AZTA vs TRVI: by the numbers
- •TRVI is the larger company ($1.87B vs $1.81B market cap).
- •Both run net losses; TRVI's is the smaller (0.00% vs -20.02% net margin).
Metrics side by side
Valuation
| Metric | AZTA | TRVI |
|---|---|---|
| Forward P/E | 79.23 | N/A |
| P/S ratio | 2.95 | N/A |
| P/B ratio | 1.20 | 5.82 |
| EV / EBITDA | 49.01 | N/A |
| FCF yield | 0.54% | N/A |
Profitability
| Metric | AZTA | TRVI |
|---|---|---|
| Gross margin | 44.05% | 0.00% |
| Operating margin | -3.49% | 0.00% |
| Net margin | -20.02% | 0.00% |
| ROE | -8.14% | -15.90% |
| ROIC | -1.33% | -18.51% |
Growth (annualized)
| Metric | AZTA | TRVI |
|---|---|---|
| Revenue CAGR (5Y) | 4.82% | N/A |
| Total return CAGR (5Y) | -15.91% | 61.74% |
Frequently asked
- How have AZTA and TRVI total returns compared?
- Over the past 5 years, AZTA delivered -15.91% and TRVI delivered 61.74% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.